cid:image001.jpg@01D158FE.B69B8D00
/sent on behalf of
Dr. Phillip Gardiner
phillip.gardiner(a)ad.umanitoba.ca
The Canadian Medical Hall of Fame
Discovery Day in Health Sciences
University of Manitoba
Friday, November 9, 2018
CALL FOR PRESENTERS PLEASE CIRCULATE AMONGST YOUR COLLEAGUES
Hi Dr. Gardiner:
We are pleased to once again partner with the Rady Faculty of Health
Sciences in offering Manitoba high school students and teachers the
opportunity to explore careers in medicine and other sciences.
We are looking for dynamic presenters to join us in this exciting outreach
initiative to educate, inspire and encourage curious minds. The objective
of the day is to get students thinking outside the box and to spark their
interest in considering a future career in the health sciences.
Our formal letter of invitation with further details is attached, along with
the days agenda and editable PDF forms. We would very much welcome the
inclusion of the Spinal Cord Research Centre in this years program. We
invite all faculty, technicians, clinicians, residents and grad/undergrad
students interested in taking part. Your assistance in circulating this
invitation amongst your colleagues would be greatly appreciated.
SUBMISSION DEADLINE: Wednesday, September 12, 2018
Questions and completed forms can be directed to my attention via email.
With thanks for your time and consideration,
Janice
Janice McNorgan
Information Systems and Program Coordinator | Coordonnatrice, Systèmes
d'information et Programmes
Canadian Medical Hall of Fame | Le Temple de la renommée médicale canadienne
202-267 Dundas Street, London ON N6A 1H2 | office: 519.488.2003 ext. 6111 |
fax: 519.488.2999
Honouring Excellence. Preserving History. Connecting Generations.
Be inspired. Explore the stories of our Laureates
<http://www.cdnmedhall.org/laureates> www.cdnmedhall.org/laureates
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or
privileged information intended for a specific individual and purpose. If
you are not the intended recipient, you are hereby notified that any
disclosure, copying, retaining, distribution, access, use or modification of
the contents of this e-mailed information is strictly prohibited. If you
receive this communication in error, please notify the sender immediately
and delete or destroy the email message and any attachments or copies.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480
cid:image001.jpg@01D158FE.B69B8D00
S P E C I A L L E C T U R E
Presented by the Manitoba Neuroscience Network, Spinal Cord Research Centre,
Regenerative Medicine Program, and Department of Physiology &
Pathophysiology
D AT E
Friday, July 27th, 2018
2 pm
L O C AT I O N
071 Apotex Bldg.
Bannatyne Campus
S P E A K E R
DR. V. WEE YONG
Professor and Canada Research Chair in Neuroimmunology
The Hotchkiss Brain Institute
University of Calgary
Director, Alberta Multiple Sclerosis Network
Past President, International Society of Neuroimmunology
T O P I C
Modulating microglia and macrophage activity to improve neurological
outcomes
Biosketch:
Dr. V. Wee Yong is a Professor at the University of Calgary, Canada, and the
Canada Research Chair in Neuroimmunology. He co-leads the Multiple Sclerosis
(MS) NeuroTeam of the Hotchkiss Brain Institute at the University of
Calgary, and he directs the provincial Alberta MS Network. Dr. Yongs
research interests lie in the area of neuroimmunology, neuroprotection and
CNS regeneration, and his projects are guided by MS and brain tumors. Dr.
Yong has published 290 peer-reviewed manuscripts and his research has been
translated into Phase III clinical trials in MS and spinal cord injury. His
work has been cited over 18,800 times by other authors (web of science;
h-index of 76). Dr. Yong is a past chair of the Medical Advisory Committee
of the MS Society of Canada; this and other volunteer activities resulted in
him receiving the Queens Golden Jubilee Year Medallion. Dr. Yong is on the
editorial board of 7 international journals; he is the Honorary
Editor-in-Chief of the journal Neuroimmunology and Neuroinflammation. He has
been the President of the International Society of Neuroimmunology
(2014-2016). Dr. Yong is an elected fellow of both the Canadian Academy of
Health Sciences and the Royal Society of Canada. He is the 2017 Allyn Taylor
International Prize in Medicine winner.
Some publications the past 5 years:
Lau L, Cua R, Keough MB, Haylock-Jacob S, Yong VW, Pathophysiology of the
brain extracellular matrix: A new target for remyelination, Nature Rev
Neurosci 14:722-729, 2013
Stephenson E, Nathoo N, Mahjoub Y, Dunn JF, Yong VW, Iron in Multiple
Sclerosis: Roles in neurodegeneration and repair, Nature Rev Neurol
10:459-468, 2014
Sarkar S, Doring A, Zemp F, Silva C, Lun X, Wang X, Kelly J, Hader W,
Hamilton M, Mercier P, Dunn JF, Kinniburgh D, van Rooijen N, Robbins S,
Forsyth P, Cairncross G, Weiss S, Yong VW, Therapeutic activation of
macrophages/microglia to suppress brain tumor-initiating cells, Nature
Neurosci 17:46-55, 2014
Keough MB, Rogers JA, Zhang P, Jensen SK, Robertson E, Chen T, Lau LW, Rawji
KS, Plemel JR, Koch M, Ling CC, Yong VW, An inhibitor of chondroitin sulfate
proteoglycan synthesis promotes CNS remyelination, Nature Communications
7:11312, 1-12, 2016
Clemente-Casares X, Blanco J, Ambalavalan P, Singha S, Yamanouchi J, Fandos
C, Tsai S, Wang J, Agrawal S, Keough M, Yong VW, James E, Moore A, Yang Y,
Stratmann T, Serra P, Santamaria P, Expanding antigen-specific regulatory
networks to treat autoimmunity, Nature b530:434-440, 2016
Mishra MK, Yong VW, Myeloid cells: targets of medications in multiple
sclerosis, Nature Rev Neurol 12:539-551, 2016
Metz LM, Li DKB, Traboulsee AL, Duquette P, Eliasziw M, Cerchiaro G,
Greenfield J, Riddehough A, Yeung M, Kremenchutzky M, Vorobeychik G,
Freedman MS, Bhan V, Blevins G, Marriott JJ, Grand'Maison F, Lee L, Thibault
M, Hill MD, Yong VW for the Minocycline in MS Study Team, Trial of
minocycline in clinically isolated syndrome of multiple sclerosis, New Engl
J Med 376:2122-2133, 2017
Plemel JR, Liu WQ, Yong VW, Remyelination therapies: a new direction and
challenge in multiple sclerosis, Nature Rev Drug Discovery 16:617-634, 2017
Faissner S, Mishra M, Wang J, Fan Y, Silva C, Rauw G, Metz L, Koch M, Yong
VW, Systematic screening of generic drugs for progressive multiple
sclerosis: Clomipramine as a promising therapeutic, Nature Communications
8:1990, 2017
Stephenson E, Mishra M, Moussienko D, Yong VW, Chondroitin sulfate
proteoglycans as novel drivers of leukocyte infiltration in multiple
sclerosis, Brain 141:1094-1110, 2018
Sarkar S, Yang R, Rawji K, Poon C, Mirzaei R, Zemp FJ, Bose P, Kelly J, Dunn
JF, Yong VW, Control of brain tumor growth by reactivating monocytes and
macrophages with niacin, resubmission invited by Science Translational Med
For more information on this lecture, please contact
Soheila Karimi
Tel: 204.272.3109
Email: Soheila.karimi(a)umanitoba.ca
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480
We are pleased to announce that Crystal Acosta (Supervisor: Hope Anderson) has been awarded this years' St. Boniface Hospital Foundation - Nick Shepel Travel Award
(a value of up to $750 CAD). This award will help to cover the travel costs associated with Crystal's attendance at the national Society for Neuroscience Meeting to present a research poster.
Congrats Crystal!
The Nick Shepel fund was established by the Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, to honor Nick Shepel who was an outstanding researcher, friend and leader. Nick was a true inspiration to his laboratory partners and brought fire, humor, and a desire to always excel. His insistence to always try better has had a permanent effect on his lab mates and peers. Nick led by example and taught that detailed preparation and execution of experiments ensured reliable results.
The purpose of this fund shall be to recognize a young investigator (specifically in the neuroscience area) by providing an annual award(s) to support travel costs associated with the applicant's attendance at an upcoming national/international conference where the applicant is presenting a poster or oral presentation.
/sent on behalf of
Paul Fernyhough
Kelly Jorundson
Administrative Manager, Division of Neurodegenerative Disorders
St. Boniface Hospital Research
Department of Pharmacology & Therapeutics
University of Manitoba
Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca> or kjorundson(a)sbgh.mb.ca <mailto:Kelly.jorundson@umanitoba.ca>
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies.
cid:image001.jpg@01D158FE.B69B8D00
/sent on behalf of
Dr. Soheila Karimi
S P E C I A L L E C T U R E
Presented by the Manitoba Neuroscience Network, Spinal Cord Research Centre,
Regenerative Medicine Program, and Department of Physiology & Pathophysiology
D AT E
Friday, July 27th, 2018
2 pm
L O C AT I O N
Room 431 - Department of Physiology and Pathophysiology
Basic Medical Sciences Bldg. Bannatyne Campus
S P E A K E R
DR. V. WEE YONG
Professor and Canada Research Chair in Neuroimmunology
The Hotchkiss Brain Institute
University of Calgary
Director, Alberta Multiple Sclerosis Network
Past President, International Society of Neuroimmunology
T O P I C
Modulating microglia and macrophage activity to improve neurological outcomes
Biosketch:
Dr. V. Wee Yong is a Professor at the University of Calgary, Canada, and the Canada Research Chair in Neuroimmunology. He co-leads the Multiple Sclerosis (MS) NeuroTeam of the Hotchkiss Brain Institute at the University of Calgary, and he directs the provincial Alberta MS Network. Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS and brain tumors. Dr. Yong has published 290 peer-reviewed manuscripts and his research has been translated into Phase III clinical trials in MS and spinal cord injury. His work has been cited over 18,800 times by other authors (web of science; h-index of 76). Dr. Yong is a past chair of the Medical Advisory Committee of the MS Society of Canada; this and other volunteer activities resulted in him receiving the Queen’s Golden Jubilee Year Medallion. Dr. Yong is on the editorial board of 7 international journals; he is the Honorary Editor-in-Chief of the journal Neuroimmunology and Neuroinflammation. He has been the President of the International Society of Neuroimmunology (2014-2016). Dr. Yong is an elected fellow of both the Canadian Academy of Health Sciences and the Royal Society of Canada. He is the 2017 Allyn Taylor International Prize in Medicine winner.
Some publications the past 5 years:
Lau L, Cua R, Keough MB, Haylock-Jacob S, Yong VW, Pathophysiology of the brain extracellular matrix: A new target for remyelination, Nature Rev Neurosci 14:722-729, 2013
Stephenson E, Nathoo N, Mahjoub Y, Dunn JF, Yong VW, Iron in Multiple Sclerosis: Roles in neurodegeneration and repair, Nature Rev Neurol 10:459-468, 2014
Sarkar S, Doring A, Zemp F, Silva C, Lun X, Wang X, Kelly J, Hader W, Hamilton M, Mercier P, Dunn JF, Kinniburgh D, van Rooijen N, Robbins S, Forsyth P, Cairncross G, Weiss S, Yong VW, Therapeutic activation of macrophages/microglia to suppress brain tumor-initiating cells, Nature Neurosci 17:46-55, 2014
Keough MB, Rogers JA, Zhang P, Jensen SK, Robertson E, Chen T, Lau LW, Rawji KS, Plemel JR, Koch M, Ling CC, Yong VW, An inhibitor of chondroitin sulfate proteoglycan synthesis promotes CNS remyelination, Nature Communications 7:11312, 1-12, 2016
Clemente-Casares X, Blanco J, Ambalavalan P, Singha S, Yamanouchi J, Fandos C, Tsai S, Wang J, Agrawal S, Keough M, Yong VW, James E, Moore A, Yang Y, Stratmann T, Serra P, Santamaria P, Expanding antigen-specific regulatory networks to treat autoimmunity, Nature b530:434-440, 2016
Mishra MK, Yong VW, Myeloid cells: targets of medications in multiple sclerosis, Nature Rev Neurol 12:539-551, 2016
Metz LM, Li DKB, Traboulsee AL, Duquette P, Eliasziw M, Cerchiaro G, Greenfield J, Riddehough A, Yeung M, Kremenchutzky M, Vorobeychik G, Freedman MS, Bhan V, Blevins G, Marriott JJ, Grand'Maison F, Lee L, Thibault M, Hill MD, Yong VW for the Minocycline in MS Study Team, Trial of minocycline in clinically isolated syndrome of multiple sclerosis, New Engl J Med 376:2122-2133, 2017
Plemel JR, Liu WQ, Yong VW, Remyelination therapies: a new direction and challenge in multiple sclerosis, Nature Rev Drug Discovery 16:617-634, 2017
Faissner S, Mishra M, Wang J, Fan Y, Silva C, Rauw G, Metz L, Koch M, Yong VW, Systematic screening of generic drugs for progressive multiple sclerosis: Clomipramine as a promising therapeutic, Nature Communications 8:1990, 2017
Stephenson E, Mishra M, Moussienko D, Yong VW, Chondroitin sulfate proteoglycans as novel drivers of leukocyte infiltration in multiple sclerosis, Brain 141:1094-1110, 2018
Sarkar S, Yang R, Rawji K, Poon C, Mirzaei R, Zemp FJ, Bose P, Kelly J, Dunn JF, Yong VW, Control of brain tumor growth by reactivating monocytes and macrophages with niacin, resubmission invited by Science Translational Med
For more information on this lecture, please contact
Soheila Karimi
Tel: 204.272.3109
Email: Soheila.karimi(a)umanitoba.ca
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca
Tel: 204.235.3939 Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts> cid:image007.png@01D29326.7E26D480 <https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro> cid:image010.png@01D29326.7E26D480
cid:image001.jpg@01D158FE.B69B8D00
/sent on behalf of
Eftekhar Eftekharpour
Everyone is invited!
REGENERATIVE MEDICINE PROGRAM
VISITING SPEAKER
DR. YUEQIN ZHOU
Cedars-Sinai Medical Centre
Neurodegenerative Disease Program
Los Angeles
"Restoring Mitofusin balance in the nervous system prevents axonal
degeneration in a CMT2A mouse model"
Thursday July 5th
2:00 P.M
Room 626 BMSB